Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             29 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 An intact signal peptide on dengue virus E protein enhances immunogenicity for CD8+ T cells and antibody when expressed from modified vaccinia Ankara Quinan, Bárbara R.
2014
32 25 p. 2972-2979
8 p.
artikel
2 A qualitative analysis of the impact of healthcare personnel influenza vaccination requirements in California Khodyakov, Dmitry
2014
32 25 p. 3082-3087
6 p.
artikel
3 A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5) Phan, Shannon I.
2014
32 25 p. 3050-3057
8 p.
artikel
4 Attenuated Mycoplasma bovis strains provide protection against virulent infection in calves Zhang, Rui
2014
32 25 p. 3107-3114
8 p.
artikel
5 Comment on “Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19+CD20+CD3−CD70−CD27+IgM+CD43+CD5+/−” Verbinnen, Bert
2014
32 25 p. 2940-2941
2 p.
artikel
6 Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza Tabynov, K.
2014
32 25 p. 2965-2971
7 p.
artikel
7 Editorial Board/Aims and Scope 2014
32 25 p. CO2-
1 p.
artikel
8 Effectiveness of the monovalent rotavirus vaccine in Colombia: A case-control study Cotes-Cantillo, Karol
2014
32 25 p. 3035-3040
6 p.
artikel
9 Effects of recruitment strategies and demographic factors on inclusion in a large scale vaccination trial in adults 65 years and older Smorenburg, Andre J.
2014
32 25 p. 2989-2994
6 p.
artikel
10 Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain Lena Trus, Ivan
2014
32 25 p. 2995-3003
9 p.
artikel
11 Estimating vaccination coverage against tick-borne encephalitis Grgič-Vitek, Marta
2014
32 25 p. 2944-
1 p.
artikel
12 Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus Morozova, O.V.
2014
32 25 p. 3101-3106
6 p.
artikel
13 Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets Onishi, Motoyasu
2014
32 25 p. 3004-3009
6 p.
artikel
14 Hepatitis A vaccination for post-exposure prophylaxis in persons aged 40 years and older Nelson, Noele P.
2014
32 25 p. 2939-
1 p.
artikel
15 Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein Uppalapati, Siva R.
2014
32 25 p. 3075-3081
7 p.
artikel
16 How advances in immunology provide insight into improving vaccine efficacy Slifka, Mark K.
2014
32 25 p. 2948-2957
10 p.
artikel
17 Human and bovine rotavirus strain antigens for evaluation of immunogenicity in a randomized, double-blind, placebo-controlled trial of a single dose live attenuated tetravalent, bovine-human-reassortant, oral rotavirus vaccine in Indian adults Paul, Anu
2014
32 25 p. 3094-3100
7 p.
artikel
18 Is it necessary to adjust for calendar time in a test negative design? Jacoby, Peter
2014
32 25 p. 2942-
1 p.
artikel
19 Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4 Gromowski, Gregory D.
2014
32 25 p. 3010-3018
9 p.
artikel
20 Optimizing benefits of influenza virus vaccination during pregnancy: Potential behavioral risk factors and interventions Christian, Lisa M.
2014
32 25 p. 2958-2964
7 p.
artikel
21 Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice Takei, Saki
2014
32 25 p. 3066-3074
9 p.
artikel
22 Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice Liu, Qiliang
2014
32 25 p. 3041-3049
9 p.
artikel
23 Reply to: Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact Wassil, James
2014
32 25 p. 2943-
1 p.
artikel
24 Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: A phase II randomized clinical trial Prymula, Roman
2014
32 25 p. 3025-3034
10 p.
artikel
25 Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP–IPV) vaccine Daley, Matthew F.
2014
32 25 p. 3019-3024
6 p.
artikel
26 Sources of information for assessing human papillomavirus vaccination history among young women Niccolai, Linda M.
2014
32 25 p. 2945-2947
3 p.
artikel
27 Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice Li, Zhong-Yuan
2014
32 25 p. 3058-3065
8 p.
artikel
28 System factors to explain H1N1 state vaccination rates for adults in US emergency response to pandemic Davila-Payan, Carlo
2014
32 25 p. 3088-3093
6 p.
artikel
29 The adjuvant component α-tocopherol triggers via modulation of Nrf2 the expression and turnover of hypocretin in vitro and its implication to the development of narcolepsy Masoudi, Sanita
2014
32 25 p. 2980-2988
9 p.
artikel
                             29 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland